Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TSX-011
- Development stage
- Phase 4
- Lead developer
- TesoRx Pharma
- Modality
- Small Molecules
- Administration
- Oral, Injectable, Intranasal, Topical
01
Overview
TSX-011 is a novel oral testosterone replacement therapy (TRT) containing testosterone undecanoate, developed to restore normal testosterone levels in hypogonadal men. Unlike most current TRT options, which are injectable, nasal, or topical and may carry risks such as inadvertent transfer of testosterone to others, TSX-011 is designed for oral administration and has demonstrated the potential for once-daily dosing. Preclinical studies indicate that it can be dosed in a fasted state without the need for fatty food intake. The drug aims to address unmet needs in hypogonadism treatment by providing an effective and convenient alternative with favorable safety and pharmacokinetic profiles[1][3][4][8].
- Brand names
- AveedJatenzoKyzatrexTlandoNebidoAndriolUndestorPantestoneRestandolRextoroReandron 1000Reandron1000Reandron-1000
- Other names
- testosterone undecylatetestosterone undeconate
02
Targets
AR (Adrenergic receptors)
Beyond the preview
Go deeper on TSX-011.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TSX-011.